Royal London Asset Management’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $273M | Sell |
577,119
-151,456
| -21% | -$76.2M | 0.57% | 25 |
|
|
2025
Q4 | $340M | Sell |
728,575
-368,376
| -34% | -$171M | 0.72% | 16 |
|
|
2025
Q3 | $468M | Sell |
1,096,951
-25,741
| -2% | -$9.98M | 1.01% | 16 |
|
|
2025
Q2 | $430M | Sell |
1,122,692
-313,325
| -22% | -$113M | 0.98% | 15 |
|
|
2025
Q1 | $496M | Sell |
1,436,017
-64,769
| -4% | -$20.8M | 1.17% | 13 |
|
|
2024
Q4 | $450M | Buy |
1,500,786
+574,239
| +62% | +$201M | 1.1% | 14 |
|
|
2024
Q3 | $377M | Sell |
926,547
-163,135
| -15% | -$59.7M | 0.93% | 17 |
|
|
2024
Q2 | $350M | Sell |
1,089,682
-169,602
| -13% | -$55.1M | 0.89% | 19 |
|
|
2024
Q1 | $420M | Sell |
1,259,284
-214,954
| -15% | -$65.7M | 1.05% | 16 |
|
|
2023
Q4 | $399M | Buy |
1,474,238
+156,757
| +12% | +$38.7M | 1.14% | 12 |
|
|
2023
Q3 | $324M | Sell |
1,317,481
-113,003
| -8% | -$30.9M | 1.05% | 16 |
|
|
2023
Q2 | $434M | Buy |
1,430,484
+107,029
| +8% | +$29.8M | 1.4% | 10 |
|
|
2023
Q1 | $349M | Buy |
1,323,455
+104,349
| +9% | +$26.5M | 1.4% | 12 |
|
|
2022
Q4 | $293M | Buy |
1,219,106
+203,466
| +20% | +$45.6M | 1.31% | 11 |
|
|
2022
Q3 | $187M | Buy |
1,015,640
+123,083
| +14% | +$24.5M | 0.95% | 17 |
|
|
2022
Q2 | $150M | Buy |
892,557
+181,243
| +25% | +$38.9M | 0.69% | 33 |
|
|
2022
Q1 | $178M | Buy |
711,314
+39,530
| +6% | +$9.93M | 0.7% | 29 |
|
|
2021
Q4 | $173M | Sell |
671,784
-56,640
| -8% | -$13.9M | 0.64% | 32 |
|
|
2021
Q3 | $177M | Buy |
728,424
+14,972
| +2% | +$3.66M | 0.72% | 27 |
|
|
2021
Q2 | $147M | Buy |
713,452
+40,197
| +6% | +$8.19M | 0.6% | 31 |
|
|
2021
Q1 | $127M | Buy |
673,255
+28,223
| +4% | +$4.98M | 0.58% | 33 |
|
|
2020
Q4 | $106M | Buy |
645,032
+352,294
| +120% | +$51.5M | 0.56% | 36 |
|
|
2020
Q3 | $35.2M | Buy |
292,738
+56,041
| +24% | +$6.94M | 0.21% | 94 |
|
|
2020
Q2 | $22.8M | Sell |
236,697
-6,173
| -3% | -$642K | 0.16% | 128 |
|
|
2020
Q1 | $22.1M | Buy |
242,870
+7,605
| +3% | +$985K | 0.18% | 131 |
|
|
2019
Q4 | $34.7M | Buy |
235,265
+1,989
| +0.9% | +$267K | 0.24% | 98 |
|
|
2019
Q3 | $28.1M | Sell |
233,276
-2,984
| -1% | -$386K | 0.21% | 110 |
|
|
2019
Q2 | $31.9M | Buy |
236,260
+11,512
| +5% | +$1.46M | 0.3% | 80 |
|
|
2019
Q1 | $29.3M | Buy |
224,748
+25,722
| +13% | +$3.45M | 0.23% | 105 |
|
|
2018
Q4 | $24.4M | Buy |
199,026
+67,729
| +52% | +$9.09M | 0.21% | 111 |
|
|
2018
Q3 | $18.3M | Buy |
131,297
+6,714
| +5% | +$836K | 0.19% | 110 |
|
|
2018
Q2 | $12.8M | Buy |
+124,583
| New | +$12.6M | 0.13% | 181 |
|
|
2016
Q2 | $8.08M | Sell |
104,885
-5,905,032
| -98% | -$466M | 0.13% | 173 |
|
|
2016
Q1 | $77K | Buy |
6,009,917
+5,897,008
| +5,223% | +$412M | 0.11% | 208 |
|
|
2015
Q4 | $7.73M | Sell |
112,909
-50,923
| -31% | -$3.55M | 0.12% | 184 |
|
|
2015
Q3 | $12.7M | Buy |
+163,832
| New | +$14.5M | 0.2% | 115 |
|
|
2014
Q4 | $78K | Buy |
105,059
+24,168
| +30% | +$1.7M | 0.15% | 162 |
|
|
2014
Q3 | $5.8M | Buy |
80,891
+7,958
| +11% | +$526K | 0.15% | 161 |
|
|
2014
Q2 | $4.89M | Sell |
72,933
-194
| -0.3% | -$10.2K | 0.11% | 205 |
|
|
2014
Q1 | $3.83M | Sell |
73,127
-2,569
| -3% | -$128K | 0.09% | 247 |
|
|
2013
Q4 | $3.88M | Buy |
75,696
+12,478
| +20% | +$577K | 0.1% | 232 |
|
|
2013
Q3 | $2.9M | Buy |
63,218
+1,119
| +2% | +$43.7K | 0.08% | 291 |
|
|
2013
Q2 | $2.26M | Buy |
+62,099
| New | +$2.4M | 0.07% | 333 |
|
Other funds holding HCA
VCM
VPM
Royal London Asset Management's HCA Position: Q1 2026 in Review
Royal London Asset Management reduced its HCA Healthcare (HCA) stake by 21% in Q1 2026, selling an estimated $76.2M and leaving 577,119 shares worth $273M. The position accounts for 0.57% of the portfolio, ranked #25.
Royal London Asset Management first reported a position in HCA in Q2 2013 and has held it in 43 quarters since. The position peaked at $496M in Q1 2025. 1,415 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Royal London Asset Management held 577,119 shares of HCA Healthcare worth $273M as of Q1 2026.
- Royal London Asset Management sold 151,456 HCA Healthcare shares in Q1 2026, an estimated $76.2M.
- HCA Healthcare made up 0.57% of Royal London Asset Management's portfolio in Q1 2026, its #25 holding.
- Royal London Asset Management first reported a position in HCA Healthcare in Q2 2013 and has held it in 43 quarters since.
- Royal London Asset Management's HCA Healthcare position peaked at $496M in Q1 2025.
- 1,415 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Royal London Asset Management's 13F filing for Q1 2026, filed 1 May 2026.